Healthcare’s most compelling growth stories often begin with an unglamorous proposition: make an existing problem less difficult to manage. For INOVIO Pharmaceuticals (NASDAQ: INO), that means a newly approved immunotherapy intended to reduce repeated surgeries. For IDEXX Laboratories (NASDAQ: IDXX), it means…
From SK hynix’s record results to Modular Medical’s European preparations, investors have more than one reason to look beyond interest-rate anxiety.
October 28, 2026
Wall Street does not need every company to thrive at once. It needs enough businesses to demonstrate that…
NYSE trading floor with screens showing stocks sliding as rising U.S. Treasury yields and Walmart (WMT) earnings pressure risk assets on August 20, 2026.
NYSE trading floor with screens showing stocks sliding as rising U.S. Treasury yields and Walmart (WMT) earnings pressure risk assets on August 20, 2026.
A national pharmacy benefit manager contract, new digital learning tools and a focused launch strategy give the insulin-pump developer a more concrete commercial narrative.
Modular Medical, Inc. (NASDAQ: MODD) is assembling something many tend to appreciate more than another promising product presentation:…
NYSE trading floor with screens showing stocks sliding as rising U.S. Treasury yields and Walmart (WMT) earnings pressure risk assets on August 20, 2026.
Amylyx Pharmaceuticals, Inc. (NASDAQ: AMLX) has delivered the kind of Phase 3 result biotechnology investors wait patiently—and, on occasion, not so patiently—for. The company reported that avexitide reduced the composite rate of severe and clinically meaningful post-bariatric hypoglycemia events by 55% versus…
The diabetes-device sector is showing signs of a more interesting ailment for Wall Street: a shortage of skepticism. Tandem Diabetes Care, Inc. (NASDAQ: TNDM) is pairing renewed financial discipline with product expansion, while Modular Medical, Inc. (NASDAQ: MODD) is taking its Pivot…
Eli Lilly and Company’s (NYSE: LLY) recent equity investment in ŌURA Health and the Oura Ring ecosystem, paired with Modular Medical’s (NASDAQ: MODD) launch of its Pivot tubeless insulin patch pump, is giving Wall Street a preview of what next‑generation metabolic care…
A San Diego upstart armed with FDA clearance, first commercial shipments, and an audacious two-part pump design is stepping into a multi-billion-dollar market that the industry's giants have repeatedly fumbled
The Patient Nobody Wanted to Build For
For decades, the diabetes device…
